NeuroSync

About

NeuroSync, based in Palo Alto, California, is a neurotechnology company focused on digital health solutions. Formerly known as SyncThink, the company rebranded in 2022. NeuroSync specializes in assessing brain health, delivering therapy, and optimizing performance through advanced technologies, including Artificial Intelligence and eye-tracking software. The company offers a digital health platform that provides actionable data for clinicians and researchers. Key products include EYE-SYNC, an FDA-cleared technology that uses eye-tracking metrics for rapid brain health assessments, customizable assessment workflows for quick diagnostics, and dynamically immersive therapeutics that leverage Virtual Reality and Augmented Reality. NeuroSync's solutions are utilized by over 4,000 providers at prominent medical centers and in collaboration with various organizations in professional and collegiate sports. The company is dedicated to enhancing neurological care and improving patient outcomes through precise diagnostics and innovative treatment plans.